<DOC>
	<DOCNO>NCT01293396</DOCNO>
	<brief_summary>The aim study investigate meal-related treatment either premixed Insulin Aspart 30 , Aspart 70 Aspart regard postprandial glucose , triglyceride free fatty acid excursion standard breakfast lunch .</brief_summary>
	<brief_title>Comparison Premixed Insulins Aspart 30 , Aspart 70 Aspart Postprandial Lipids</brief_title>
	<detailed_description>Whereas effect establish type insulin ( BiAsp30 , BiAsp70 , Insulin Aspart ) show , specific glucose lipid lower capacity far investigate simulated physiological situation .</detailed_description>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin degludec , insulin aspart drug combination</mesh_term>
	<mesh_term>Insulin aspart , insulin aspart protamine drug combination 30:70</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Biphasic Insulins</mesh_term>
	<mesh_term>Insulin Aspart</mesh_term>
	<mesh_term>Insulin , Long-Acting</mesh_term>
	<mesh_term>Insulin , Isophane</mesh_term>
	<criteria>TypeII Diabetes BMI &gt; 27 kg/m2 age 35 75 year HbA1c &lt; 8.5 % informed consent treatment premixed insulin stabile dose insulin least 4 week TypeI Diabetes mellitus HbA1c &gt; 8.5 % Serum Creatinine &gt; 1.7 mg/dl ALT AST &gt; 3x ULN treatment sulfonylurea gliptins treatment glitazones manifest clinical infection treatment glucocorticoid antipsychotic drug psychiatric disease alcohol abuse myocardial infarction stroke within previous 3 month surgery within previous 3 month</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>September 2011</verification_date>
	<keyword>insulin aspart 30</keyword>
	<keyword>insulin aspart 70</keyword>
	<keyword>insulin aspart</keyword>
	<keyword>postprandial glucose lipid metabolism</keyword>
	<keyword>consecutive mixed meal</keyword>
</DOC>